| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Amphotericin B induces epithelial voltage responses in people with cystic fibrosis
|
Chorghade, Rajeev S.
|
|
|
20 |
3 |
p. 540-550
|
article
|
| 2 |
Antimicrobial resistance: Concerns of healthcare providers and people with CF
|
Bullington, Wendy
|
|
|
20 |
3 |
p. 407-412
|
article
|
| 3 |
Balancing the benefits of antimicrobial therapy with the threat of antimicrobial resistance development
|
Lee, Andrew
|
|
|
20 |
3 |
p. 377-378
|
article
|
| 4 |
Barrier to using APRI and GPR as identifiers of cystic fibrosis liver disease
|
Sellers, Zachary M.
|
|
|
20 |
3 |
p. 551
|
article
|
| 5 |
Baseline Cystic fibrosis disease severity has an adverse impact on pregnancy and infant outcomes, but does not impact disease progression
|
Cohen-Cymberknoh, Malena
|
|
|
20 |
3 |
p. 388-394
|
article
|
| 6 |
Beyond phenotype: The genomic heterogeneity of co-infecting Mycobacterium abscessus smooth and rough colony variants in cystic fibrosis patients
|
Gutiérrez, Ana Victoria
|
|
|
20 |
3 |
p. 421-423
|
article
|
| 7 |
Biliary disease and cholecystectomy after initiation of elexacaftor/ivacaftor/tezacaftor in adults with cystic fibrosis
|
Safirstein, Julie
|
|
|
20 |
3 |
p. 506-510
|
article
|
| 8 |
CFTR modulator therapy for cystic fibrosis caused by the rare c.3700A>G mutation
|
Phuan, Puay-Wah
|
|
|
20 |
3 |
p. 452-459
|
article
|
| 9 |
CFTR plays an important role in the regulation of vascular resistance and high-fructose/salt-diet induced hypertension in mice
|
Zhang, Ya-Ping
|
|
|
20 |
3 |
p. 516-524
|
article
|
| 10 |
Challenges in the use of highly effective modulator treatment for cystic fibrosis
|
Ramos, Kathleen J.
|
|
|
20 |
3 |
p. 381-387
|
article
|
| 11 |
Concerns regarding the safety of azithromycin in pregnancy - relevance for women with cystic fibrosis
|
Taylor-Cousar, Jennifer L.
|
|
|
20 |
3 |
p. 395-396
|
article
|
| 12 |
Dornase alfa and rate of lung function decline in European patients with cystic fibrosis: A retrospective registry cohort study
|
McKone, Edward F.
|
|
|
20 |
3 |
p. 552-554
|
article
|
| 13 |
Early acquisition and conversion of Pseudomonas aeruginosa in Hispanic youth with cystic fibrosis in the United States
|
McGarry, Meghan E.
|
|
|
20 |
3 |
p. 424-431
|
article
|
| 14 |
Early disease surveillance in young children with cystic fibrosis: A qualitative analysis of parent experiences
|
Douglas, Tonia A
|
|
|
20 |
3 |
p. 511-515
|
article
|
| 15 |
Editorial Board
|
|
|
|
20 |
3 |
p. ii
|
article
|
| 16 |
Effect of highly effective modulator treatment on sinonasal symptoms in cystic fibrosis
|
DiMango, Emily
|
|
|
20 |
3 |
p. 460-463
|
article
|
| 17 |
Electronic health nudges to improve reproductive health care for women with cystic fibrosis
|
Roe, Andrea H.
|
|
|
20 |
3 |
p. 397-398
|
article
|
| 18 |
Elexacafator/tezacaftor/ivacaftor resolves subfertility in females with CF: A two center case series
|
O'Connor, Kate E.
|
|
|
20 |
3 |
p. 399-401
|
article
|
| 19 |
Exon identity influences splicing induced by exonic variants and in silico prediction efficacy
|
Martin, Natacha
|
|
|
20 |
3 |
p. 464-472
|
article
|
| 20 |
Extensive CFTR sequencing through NGS in Brazilian individuals with cystic fibrosis: unravelling regional discrepancies in the country
|
da Silva Filho, Luiz Vicente Ribeiro Ferreira
|
|
|
20 |
3 |
p. 473-484
|
article
|
| 21 |
Heat acclimation improves sweat gland function and lowers sweat sodium concentration in an adult with cystic fibrosis
|
Willmott, Ashley G.B.
|
|
|
20 |
3 |
p. 485-488
|
article
|
| 22 |
K162E - A rare and uncategorized CFTR variant causing cystic fibrosis
|
Souza, Edna Lúcia
|
|
|
20 |
3 |
p. 489-491
|
article
|
| 23 |
Long-term bone mineral density changes and fractures in lung transplant recipients with cystic fibrosis
|
Durette, Gabrielle
|
|
|
20 |
3 |
p. 525-532
|
article
|
| 24 |
Low rates of macrolide-resistant Mycobacterium avium complex in cystic fibrosis despite chronic azithromycin therapy
|
Richter, William J.
|
|
|
20 |
3 |
p. 555-557
|
article
|
| 25 |
Maternal and fetal outcomes following elexacaftor-tezacaftor-ivacaftor use during pregnancy and lactation
|
Taylor-Cousar, Jennifer L.
|
|
|
20 |
3 |
p. 402-406
|
article
|
| 26 |
Newborn screening alone insufficient to improve pulmonary outcomes for cystic fibrosis
|
Barreda, Christina B.
|
|
|
20 |
3 |
p. 492-498
|
article
|
| 27 |
News article
|
|
|
|
20 |
3 |
p. 379-380
|
article
|
| 28 |
Organoids for personalized treatment of Cystic Fibrosis: Professional perspectives on the ethics and governance of organoid biobanking
|
Lensink, Michael A.
|
|
|
20 |
3 |
p. 443-451
|
article
|
| 29 |
Patient and family perceptions of telehealth as part of the cystic fibrosis care model during COVID-19
|
Davis, J.
|
|
|
20 |
3 |
p. e23-e28
|
article
|
| 30 |
Pregnancy in women with Cystic Fibrosis in the 21st century
|
Middleton, Peter G
|
|
|
20 |
3 |
p. 375-376
|
article
|
| 31 |
SARS-CoV-2 and Burkholderia cenocepacia infection in a patient with Cystic Fibrosis: An unfavourable conjunction?
|
Olcese, C.
|
|
|
20 |
3 |
p. e29-e31
|
article
|
| 32 |
Sensitive structural and functional measurements and 1-year pulmonary outcomes in pediatric cystic fibrosis
|
Willmering, Matthew M.
|
|
|
20 |
3 |
p. 533-539
|
article
|
| 33 |
Sputum versus nasopharyngeal samples for the molecular diagnosis of respiratory viral infection in cystic fibrosis: A pilot study
|
Cardot-Martin, Emilie
|
|
|
20 |
3 |
p. 432-435
|
article
|
| 34 |
Targeting G542X CFTR nonsense alleles with ELX-02 restores CFTR function in human-derived intestinal organoids
|
Crawford, Daniel K.
|
|
|
20 |
3 |
p. 436-442
|
article
|
| 35 |
The cystic fibrosis gut as a potential source of multidrug resistant pathogens
|
Taylor, Steven L.
|
|
|
20 |
3 |
p. 413-420
|
article
|
| 36 |
VO2max as an exercise tolerance endpoint in people with cystic fibrosis: Lessons from a lumacaftor/ivacaftor trial
|
Wilson, John
|
|
|
20 |
3 |
p. 499-505
|
article
|
Journal description